ATBF1 has been demonstrated to be a potential diagnostic marker for skin cancer, prostate cancer, gastric cancer, bladder cancer and non-small cell lung cancer (NSCLC) [9, 12, 13, 32]. Here, ZFHX3 is linked to urinary bladder carcinoma.